Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer

NCT01718626 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: S1+Docetaxel
DRUG: S1+Docetaxel followed by S1

Sponsor

Hebei Tumor Hospital